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SEMINAL CONTRIBUTIONTherapeutic endometrial scratching
and implantation after in vitro
fertilization: a multicenter
randomized controlled trial
Mia Steengaard Olesen, M.D., Ph.D.,a Benedicte Hauge, M.D.,a Lisbeth Ohrt, B.SN.,a
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Bugge Nøhr, M.D., Ph.D.,d Mette Nyegaard, MSc, Ph.D.,e Michael Toft Overgaard, Ph.D., Professor,f
Peter Humaidan, D.M.Sc.,c Axel Forman, D.M.Sc.,g and Inge Agerholm, M.Sc., Ph.D.a
a Fertility Clinic, Horsens Regional Hospital, Horsens; b Fertility Clinic, Aalborg University Hospital, Aalborg; c Fertility Clinic,
Skive Regional Hospital, Skive; d Fertility Clinic, Department of Obstetrics and Gynecology, Herlev Hospital, Copenhagen
University Hospital, Herlev; e Department of Biomedicine, Aarhus University, Aarhus; f Department of Chemistry and
Bioscience, Aalborg University, Aalborg; and g Department of Gynecology and Obstetrics, Aarhus University Hospital,
Aarhus, DenmarkObjective: To study whether endometrial scratching in the luteal phase before ovarian stimulation increases clinical pregnancy rates in
women with one or more previous implantation failures.
Design: A nonblinded multicenter randomized clinical trial.
Setting: Fertility clinics.
Patient(s): Three hundred four eligible patients scheduled for IVF/intracytoplasmic sperm injection were randomized. The intervention
group (n¼ 151) underwent endometrial scratching in the luteal phase before controlled ovarian stimulation, while no intervention was
performed in the control group (n ¼ 153).
Intervention(s): Endometrial scratching with a Pipelle de Cornier catheter in the luteal phase before ovarian stimulation.
Main Outcome Measure(s): Clinical pregnancy rate and prenatal and birth data.
Result(s): There was no overall significant improvement in clinical pregnancy rates between the control and intervention groups
(38.5% vs. 44.4%; relative risk ¼ 1.15; confidence interval [0.86–1.55]). However, subgroup analyses revealed that women with three
or more previous implantation failures had a significant increase in clinical pregnancy rate (31.1% vs. 53.6%; relative risk¼ 1.72; con-
fidence interval [1.05–2.83]) after scratching. No difference was seen as regards prenatal and birth data between the two groups.
Conclusion(s): Endometrial scratching in the luteal phase before ovarian stimulation significantly enhances the clinical pregnancy
rate in women with three or more prior implantation failures. This result seems to corroborate previous reports, which found that partic-
ularly women with repeated implantation failure seem to gain a positive effect from endometrial scratching. Importantly, there were no
significant differences in prenatal data and birth data between the groups.
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I mplantation is the rate-limiting step of pregnancy (1);however, previous studies have indicated that therapeuticendometrial scratching may enhance implantation in as-
sisted reproductive technology (ART) (2–4). The benefit of
endometrial scratching in humans was initially reported as
a serendipitous finding because a high pregnancy rate was
observed in IVF women who had undergone repeated
endometrial biopsies during their preceding natural
menstrual cycle. This led to the first published study on 134
patients, which showed a twofold increase in live birth rate
(48.9% vs 22.5 %) (5). Subsequently, a number of studies
have indicated a potential clinical value of this intervention
(4, 6, 7), particularly in repeated implantation failure (RIF)
patients (5, 8–10), while others failed to detect a benefit in
patients, mainly in those undergoing their first or second
IVF attempt (11–15). In contrast, a randomized controlled
trial (RCT) showed that endometrial scratching carried out
on the day of oocyte pickup resulted in a reduction of
approximately two-thirds in the implantation rate in compar-
ison with the control group (16). Since there is no consensus
regarding the timing and optimal number of scratchings, het-
erogeneity exists in the current studies, and caution has been
advised against extrapolating from these studies (17, 18).
Only a few studies (4, 6, 11, 15) reported live birth rates,
and only one study reported prenatal and birth data on the
children born (15). Furthermore, only two studies had
adequate power to draw reliable conclusions (11, 15).
The aim of this study was to investigate the impact of
endometrial scratching on the clinical pregnancy rate in a
nonblindedmulticenter randomized controlled trial in women
with one or more prior implantation failures. Secondary out-
comes were implantation rate (defined as the number of
gestational sacs observed at vaginal ultrasound after transfer
divided by the number of transferred embryos), ongoing
pregnancy rate, live birth rate, miscarriage rate (defined as
the number of miscarriages per cycle initiated), multiple preg-
nancy rate, prenatal data, and offspring data.
SEMINAL CONTRIBUTIONMATERIALS AND METHODS
Ethics
The study was approved by the local Research Ethics Commit-
tee (1-10-72-72-13) and the Danish Data Protection Agency
(1-16-02-115-13) and was registered at www.clinicaltrials.
gov (NCT01963819). The study is reported according to the
CONSORT guidelines.Study Design and Participants
Patients were recruited during the period of February 2014 to
December 2017 at four public fertility clinics in Denmark:
Horsens Regional Hospital, Aalborg University Hospital,
Skive Regional Hospital, and Herlev University Hospital.
Eligible patients were IVF or intracytoplasmic sperm injection
patients with one or more prior implantation failures, despite
top-quality embryo or blastocyst (19) transfer(s). Further in-
clusion criteria were regular menstrual cycle (28–32 days),
age 18–40 years, and a body mass index (BMI) 18–32 kg/
m2. Women with congenital uterine abnormalities, fibroids,1016or polyps were excluded, as were women with suspected hy-
drosalpinges and adenomyosis.Randomization
After providing informed consent, the participants were ran-
domized into blocks of 10 for each participating clinic in a ra-
tio of 1:1, according to an Internet-based randomization list
that was sealed in consecutively numbered opaque envelopes.
The study was nonblinded, and no sham procedure was car-
ried out in the control group.Endometrial Scratching
Scratching was performed, using a Pipelle de Cornier (Labora-
toires Prodimed) in the luteal phase before ovarian stimula-
tion at cycle day 18–22 for the intervention group. The
scratching was carried out with the patient lying in a lithot-
omy position and was performed once in each quadrant of
the endometrium. Biopsies were snap frozen at –80C.ART
Participants were cotreated in a GnRH-antagonist protocol
using recombinant FSH (rFSH) for controlled ovarian stimu-
lation starting on cycle day 2 or 3 and a GnRH antagonist
(0.25 mg/day Orgalutran, MSD) from stimulation day 5 to
prevent premature luteinization. Patients were triggered
with 6,500 IU hCG (Ovitrelle, Merck). Oocytes were retrieved
and fertilized by either IVF or intracytoplasmic sperm injec-
tion, and a maximum of two embryos were transferred after
2–5 days of culture. Luteal-phase support was provided by
vaginal P gel (Crinone 90 mg/dose, Merck) from the day after
oocyte retrieval until the day of hCG testing (12–14 days after
transfer).Sample Size Calculation
The sample size for the RCT was based on a clinical pregnancy
rate of 31% in the four participating clinics. To detect a 50%
increase in clinical pregnancy rate (i.e., from 31% to 47%) at a
significance level of P¼ .05 and a power of 0.80, we needed
146 participants in each group, in total, 292 participants.Statistical Methods
Comparisons of the cycle characteristics were performed us-
ing a t test, Mann-Whitney U test, or c2 test. An intention
to treat (ITT) analysis included all participants who were ran-
domized, regardless of whether they completed full treatment
or dropped out. Further, a per-protocol (PP) analysis of the
participants who complied with their randomized treatment
was performed to compare reproductive outcomes. A sub-
group analysis was performed comparing reproductive
outcome according to previous implantation failure (i.e.,
one, two, or three or more previous failed implantations).
Two-sided P < .05 was considered statistically significant.
Confidence intervals (CIs) were given at 95%. All statistical
work was performed in STATA, 15.0 (StataCorp).VOL. 112 NO. 6 / DECEMBER 2019
Fertility and Sterility®RESULTS
In total, 304 Caucasian womenwere included according to the
CONSORT guidelines (Fig. 1). Of the 304 patients, 151 women
were randomized to endometrial scratching and 153 patients
to the control group. In all, 254 women completed the study
with ET. There were no uterine infections, bleeding, or adverse
events reported, besides a short pain during the endometrial
scratching procedure.FIGURE 1
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VOL. 112 NO. 6 / DECEMBER 2019Patients and Cycle Characteristics
Patients' baseline characteristics were well balanced with
respect to age, BMI, indication of infertility, smoking, alcohol
consumption, sum of previous transfers (including fresh and
frozen transfers), and prior parity in both groups
(Supplemental Table 1). Furthermore, there were no signifi-
cant differences between the two groups with respect to cycle
characteristics, as shown in Supplemental Table 2.Proceeded to embryo transfer (n= 130)
No embryo transfer (n= 16)
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10 Paents with non-transferable embryos
Analyzed (n=153)
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Reproductive outcomes of the endometrial scratch and non-
scratch groups are listed in Table 1. There was no overall sig-
nificant difference in the clinical pregnancy rate when
comparing the scratch group to the nonscratch group based
on ITT analysis: 36.4% versus 32.7%; relative risk (RR) ¼
1.11; CI (0.82–1.52), P¼ .492; and based on PP analysis:
44.4% versus 38.5%; RR ¼ 1.15; CI (0.86–1.55), P¼ .340.
Furthermore, no significant differences were found in im-
plantation rate, ongoing pregnancy rate, live birth rate,
miscarriage rate, and multiple pregnancy rate between the
scratch and nonscratch group.Subgroup Analyses
Subgroup analyses were performed by stratifying according
to previous implantation failure (i.e., one, two, or three or
more previous failed implantations). We found no significant
difference between the scratch and nonscratch group within
the two subgroups with one and two previous implantation
failures.
Conversely, the subgroup of women with three or more
previous implantation failures had a significant increase in
reproductive outcome after scratching based on ITT analyses,
namely, we found a significant increase in clinical pregnancy
rate in the scratch group: 45.5% versus 27.5%; RR ¼ 1.66; CI
(1.01–2.78), P¼ .046. Based on PP analysis, when comparing
the scratch and nonscratch groups, the following results were
found with respect to clinical pregnancy rate: 53.6% versus
31.1%; RR ¼ 1.72, CI (1.05–2.83), P¼ .024; ongoing preg-
nancy rate: 46.4% versus 26.7%; RR ¼ 1.74, CI (1.00–3.05),
P¼ .042); and live birth rate: 46.4% versus 26.7%; RR ¼
1.74, CI (1.00–3.05), P¼ .042. The subgroup analyses are listed
in Table 2.
Subgroup analyses of baseline and cycle characteristics
according to previous implantation failures are given inTABLE 1
Reproductive outcomes of the endometrial scratch and nonscratch groups
of the participants complying with their randomization.
Variable Scratch group (n [ 151) Non
Clinical pregnancy rate 55/151 (36.4)
Ongoing pregnancy rate 47/151 (31.1)
Live birth rate 47/151 (31.1)
Miscarriage rate 11/151 (7.3)
A
Scratch group (n [ 124) Non
Clinical pregnancy rate 55/124 (44.4)
Ongoing pregnancy rate 47/124 (37.9)
Live birth rate 47/124 (37.9)
Miscarriage rate 11/124 (8.9)
Implantation rate 58/153 (37.9)
Multiple pregnancy rate 3/55 (5.5)
Note: Data in parentheses are percentages unless otherwise indicated.
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except for a significant difference in male factor infertility in
the subgroup of women with three or more previous implan-
tation failures (P¼ .043). Due to the Danish national policy of
single ET, the multiple pregnancy rate was overall low, with
three pairs of twins in total; the multiple pregnancy rate
was therefore not given for the subgroup analyses. Further-
more, pregnancy rates by diagnosis are shown in
Supplemental Table 4.Prenatal Data and Birth Data
In total 87 children were born. In the endometrial scratch
group, 50 children were born, including three pairs of twins.
Prenatal data were comparable with respect to preeclampsia,
intrauterine growth restriction (IUGR), gestational diabetes
(GDM), and preterm birth (gestational age < 36 þ 6 weeks).
Furthermore, no significant differences in birth data were
observed, including sex, length and birth weight, malforma-
tions/birth defects, and placenta malformations. The prenatal
and birth data are listed in Table 3.DISCUSSION
This multicenter RCT shows that endometrial scratching in the
luteal phase before ovarian stimulation does not increase
overall clinical pregnancy rates in women with one or more
prior implantation failures. However, subgroup analyses indi-
cate an increase in the clinical pregnancy rate in women with
three or more previous implantation failures. These results are
consistent with previous research that reported that women
with RIF in particular may benefit from endometrial scratch-
ing (5, 8–10, 12), while no significant improvement could be
demonstrated in unselected subfertile women (11, 13, 15).
Since embryo quality has been estimated to account for
two-thirds of all implantation failures, a nonreceptive endo-
metrium could be responsible for the remaining one-thirdusing an ITT analysis of the randomized participants and a PP analysis
ITT analysis (n [ 304)
P valuescratch group (n [ 153) RR (95% CI)
50/153 (32.7) 1.11 (0.82–1.52) .492
37/153 (24.2) 1.29 (0.89–1.86) .176
37/153 (24.2) 1.29 (0.89–1.86) .176
16/153 (10.5) 0.70 (0.33–1.45) .331
nalysis per protocol (n [ 254)
scratch group (n [ 130) RR (95% CI) P value
50/130 (38.5) 1.15 (0.86–1.55) .340
37/130 (28.5) 1.33 (0.94–1.90) .110
37/130 (28.5) 1.33 (0.94–1.90) .110
16/130 (12.3) 0.72 (0.35–1.49) .374
50/158 (31.6) 1.20 (0.88–1.63) .246
0/50 (0) .094




One previous failed implantation (n [ 108)
Scratch group (n [ 47) Nonscratch group (n [ 61) RR (95% CI) P value
Clinical pregnancy rate 18/47 (38.3) 19/61 (31.1) 1.23 (0.73–2.07) .438
Ongoing pregnancy rate 15/47 (31.9) 14/61 (23.0) 1.39 (0.75–2.59) .297
Live birth rate 15/47 (31.9) 14/61 (23.0) 1.39 (0.75–2.59) .297
Miscarriage rate 4/47 (8.5) 8/61 (13.1) 0.65 (0.21–2.03) .450
PP Scratch group (n [ 37) Nonscratch group (n [ 49) RR (95% CI) P value
Clinical pregnancy rate 18/37 (48.6) 19/49 (38.8) 1.25 (0.77–2.03) .360
Ongoing pregnancy rate 15/37 (40.5) 14/49 (28.6) 1.42 (0.79–2.56) .245
Live birth rate 15/37 (40.5) 14/49 (28.6) 1.42 (0.79–2.56) .245
Miscarriage rate 4/37 (10.8) 8/49 (16.3) 0.66 (0.22–2.03) .465
Implantation rate 18/45 (40) 22/61 (36.1) 1.11 (0.68–1.81) .680
ITT
Two previous failed implantations (n [ 79)
Scratch group (n [ 38) Nonscratch group (n [ 41) RR (95% CI) P value
Clinical pregnancy rate 7/38 (18.4) 14/41 (34.1) 0.54 (0.24–1.19) .114
Ongoing pregnancy rate 6/38 (15.8) 11/41 (26.8) 0.59 (0.24–1.44) .233
Live birth rate 6/38 (15.8) 11/41 (26.8) 0.59 (0.24–1.44) .233
Miscarriage rate 2/38 (5.3) 6/41 (14.6) 0.36 (0.08–1.67) .168
PP Scratch group (n [ 31) Nonscratch group (n [ 36) RR (95% CI) P value
Clinical pregnancy rate 7/31 (22.6) 14/36 (38.9) 0.58 (0.27–1.25) .151
Ongoing pregnancy rate 6/31 (19.4) 11/36 (30.6) 0.63 (0.27–1.51) .294
Live birth rate 6/31 (19.4) 11/36 (30.6) 0.63 (0.27–1.51) .294
Miscarriage rate 2/31 (6.5) 6/36 (16.7) 0.39 (0.08–1.78) .199
Implantation rate 8/38 (21.1) 14/45 (31.1) 0.68 (0.32–1.44) .301
ITT
Three or more previous failed implantations (n [ 117)
Scratch group (n [ 66) Nonscratch group (n [ 51) RR (95% CI) P value
Clinical pregnancy rate 30/66 (45.5) 14/51 (27.5) 1.66 (1.01–2.78) .046a
Ongoing pregnancy rate 26/66 (39.4) 12/51 (23.5) 1.67 (0.94–2.98) .069
Live birth rate 26/66 (39.4) 12/51 (23.5) 1.67 (0.94–2.98) .069
Miscarriage rate 5/66 (7.6) 2/51 (3.9) 1.93 (0.39–9.35) .409
PP Scratch group (n [ 56) Nonscratch group (n [ 45) RR (95% CI) P value
Clinical pregnancy rate 30/56 (53.6) 14/45 (31.1) 1.72 (1.05–2.83) .024a
Ongoing pregnancy rate 26/56 (46.4) 12/45 (26.7) 1.74 (1.00–3.05) .042a
Live birth rate 26/56 (46.4) 12/45 (26.7) 1.74 (1.00–3.05) .042a
Miscarriage rate 5/56 (8.9) 2/45 (4.4) 2.01 (0.41–9.87) .378
Implantation rate 32/70 (45.7) 14/52 (26.9) 1.70 (1.01–2.84) .034a
Note: Data in parentheses are percentages unless otherwise indicated. Reproductive outcomes stratified for one, two, and three or more implantation failures using an ITT and PP analysis.
a Statistically significant.
Olesen. Scratching for RIF patients only. Fertil Steril 2019.
Fertility and Sterility®(1). The subgroup of women with RIF are therefore more likely
to have an endometrium-associated implantation failure, in
contrast to the subgroup of women with one or two previous
implantation failures. This result echoes a recent finding in
which RIF patients were reported to have a specific endome-
trial gene expression profile predictive of RIF when compared
with non RIF patients (20). To conclude that endometrial
scratching may enhance the clinical pregnancy rate in RIF pa-
tients, we compared baseline and cycle characteristics in the
subgroups as well (Supplemental Table 3). We found no dif-
ferences except for male factor infertility in the subgroup of
women with three or more implantation failures. However,
none of the other parameters significantly differ from each
other, especially the quality of the transferred embryos.VOL. 112 NO. 6 / DECEMBER 2019Moreover, patients with male factor infertility had similar
rates of clinical pregnancy, ongoing pregnancy, and live birth
rate compared with patients with other causes of infertility
(Supplemental Table 4). We therefore find this difference of
minor importance and unlikely to create bias.
The studies of Yeung et al. (11) and Lensen et al. (15) were
well powered (n ¼ 300 patients and n ¼ 1,364, respectively).
Our study differs from that of Lensen et al. in that their study
allowed marked heterogeneity, that is, fresh and frozen ETs,
and a broad timing of endometrial scratching; also their defi-
nition of RIF differs from our study. This makes it a very
generalizable and pragmatic study but difficult to compare
with our study. Conversely, our study resembles the study
of Yeung et al. in timing, number of endometrial scratchings,1019
TABLE 3
Prenatal and birth data of the endometrial scratch group and nonscratch group (84 women, 87 children).
Variable
Scratch group
(50 children, 47 women)
Nonscratch group
(37 children, 37 women) P value
Preeclampsia 5/47 (10.6) 2/37 (5.4) .389
IUGR 2/47 (4.3) 3/37 (8.1) .439
GDM 2/47 (4.3) 2/37 (5.4) .806
Preterm birth (gestational
age < 36þ6 wk)
7/47 (14.9) 4/37 (10.8) .396
Sex male 22/50 (44.0) 20/37 (54.1) .354
Sex female 28/50 (56.0) 17/37 (45.9) .354
Length at birth, cm 50.26  2.97 50.84  2.85 .367
Weight at birth 3,242  623 3,358  699 .427
Birth defects/malformations 0 0
Placenta malformations 4/47 (8.5) 3/37 (8.1) .947
Note: Data in parentheses are percentages.
Olesen. Scratching for RIF patients only. Fertil Steril 2019.
SEMINAL CONTRIBUTIONand sample size, but our patient population is different
because we included only women with one or more previous
implantation failures. Noticeably, 69.7% of the recruited
women were first-attempt IVF patients in the aforementioned
study, which could be the reason why the results may not be
generalizable to all women undergoing IVF, as also
mentioned by the authors (11). This emphasizes how impor-
tant it is to distinguish between patient populations, for
example, previous implantation failures, when evaluating
the effect of endometrial scratching. Further, a standard defi-
nition of RIF would be required as well as a consensus
regarding the optimal number and timing of endometrial
scratching(s).
A major strength of our RCT is that we included live birth
rate, prenatal data, and birth data. This allows us not only to
investigate whether endometrial scratching enhances repro-
ductive outcomes in women with one or more prior implanta-
tion failures, but also to verify that no adverse effects are
induced in pregnancy or in the children born after this inter-
vention. In this context especially, implantation-related dis-
orders such as preeclampsia and IUGR are of interest.
Although our sample size was too small to claim any statisti-
cal significance of this observation, it is certainly of
importance.
An additional strength is the sample size, which increases
the statistical accuracy and strengthens our knowledge of
endometrial scratching as a possible therapeutic intervention.
Some limitations of the study are that it was nonblinded
and no sham procedure was used, but because clinical preg-
nancy rate is an objective outcome, these factors are unlikely
to create bias.
Further, during recruitment for this study, a paradigm
shift from cleavage culture to extended culture was impend-
ing at the different participating clinics. Another potential
limitation of this study is, therefore, that it allowed marked
heterogeneity, that is, combining the transfer of cleavage-
and blastocyst-stage embryos and transfer of one or two
embryos. Ideally, the study protocol should have been more
standardized. However, randomization should reduce the1020chance of biasing the results. Lastly, our sample size calcula-
tion did not plan for more than 10% dropouts during the study
(i.e., 304 women were randomized, and 254 women
completed the transfer); therefore, the results of the PP anal-
ysis should be interpreted with caution. Despite these limita-
tions, our study contributes to knowledge regarding a possible
therapeutic intervention in ART for a subgroup of patients.
In conclusion, this multicenter RCT found that endome-
trial scratching in the luteal phase before ovarian stimulation
does not increase overall clinical pregnancy rates in women
with one or more previous implantation failures. However,
subgroup analyses show that women with three or more pre-
vious failed implantations have a significant increase in clin-
ical pregnancy rate with scratching. Importantly, no
differences in prenatal and birth data were seen between
scratched and nonscratched cycles.REFERENCES
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